Folate receptor α regulates cell proliferation in mouse gonadotroph αT3-1 cells

Experimental Cell Research

Volumn 315, Issue 18, 2009, Pages 3125-3132

  Yao, Congjun ^a   Evans, Chheng Orn ^a   Stevens, Victoria L ^b   Owens, Timothy R ^a   Oyesiku, Nelson M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

Cell proliferation; Cell transformation; Folate receptor; Pituitary adenomas; Real time quantitative PCR

Indexed keywords

BROXURIDINE; COMPLEMENTARY DNA; CYCLINE; FOLATE RECEPTOR; FOLATE RECEPTOR ALPHA; MESSENGER RNA; MUTANT PROTEIN; NOTCH3 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; GONADOTROPIN SECRETING CELL; HYPOPHYSIS ADENOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 70349759523     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.05.006     Document Type: Article

References (38)

1. Greenman Y., and Melmed S. Diagnosis and management of nonfunctioning pituitary tumors. Annu. Rev. Med. 47 (1996) 95-106
2. Asa S. Tumors of the Pituitary Gland (1998), Armed Forces institute of Pathology, Washington, DC
3. Levy A. Molecular and trophic mechanisms of tumorigenesis. Endocrinol. Metab. Clin. North Am. 37 (2008) 23-50
4. Asa S.L., and Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr. Rev. 19 (1998) 798-827
5. Black P.M., Hsu D.W., Klibanski A., Kliman B., Jameson J.L., Ridgway E.C., Hedley-Whyte E.T., and Zervas N.T. Hormone production in clinically nonfunctioning pituitary adenomas. J. Neurosurg. 66 (1987) 244-250
6. Katznelson L., Alexander J.M., and Klibanski A. Clinical review 45: clinically nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 76 (1993) 1089-1094
7. Moreno C.S., Evans C.O., Zhan X., Okor M., Desiderio D.M., and Oyesiku N.M. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res. 65 (2005) 10214-10222
8. Evans C.O., Reddy P., Brat D.J., O'Neill E.B., Craige B., Stevens V.L., and Oyesiku N.M. Differential expression of folate receptor in pituitary adenomas. Cancer Res. 63 (2003) 4218-4224
9. Evans C.O., Young A.N., Brown M.R., Brat D.J., Parks J.S., Neish A.S., and Oyesiku N.M. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J. Clin. Endocrinol. Metab. 86 (2001) 3097-3107
10. Farrell W.E., Simpson D.J., Bicknell J., Magnay J.L., Kyrodimou E., Thakker R.V., and Clayton R.N. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours. Br. J. Cancer 80 (1999) 44-50
11. Lubensky I.A., Debelenko L.V., Zhuang Z., Emmert-Buck M.R., Dong Q., Chandrasekharappa S., Guru S.C., Manickam P., Olufemi S.E., Marx S.J., Spiegel A.M., Collins F.S., and Liotta L.A. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res. 56 (1996) 5272-5278
12. Rijnboutt S., Jansen G., Posthuma G., Hynes J.B., Schornagel J.H., and Strous G.J. Endocytosis of GPI-linked membrane folate receptor-alpha. J. Cell Biol. 132 (1996) 35-47
13. Miotti S., Canevari S., Menard S., Mezzanzanica D., Porro G., Pupa S.M., Regazzoni M., Tagliabue E., and Colnaghi M.I. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int. J. Cancer 39 (1987) 297-303
14. Shen F., Ross J.F., Wang X., and Ratnam M. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 33 (1994) 1209-1215
15. Chung K.N., Saikawa Y., Paik T.H., Dixon K.H., Mulligan T., Cowan K.H., and Elwood P.C. Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates. J. Clin. Invest. 91 (1993) 1289-1294
16. Ross J.F., Chaudhuri P.K., and Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73 (1994) 2432-2443
17. Sun X.L., Jayaram H.N., Gharehbaghi K., Li Q.J., Xiao X., and Antony A.C. Modulation of the cytotoxicity of 3′-azido-3′-deoxythymidine and methotrexate after transduction of folate receptor cDNA into human cervical carcinoma: identification of a correlation between folate receptor expression and thymidine kinase activity. Cancer Res. 59 (1999) 940-946
18. Qian X., Jin L., Kulig E., and Lloyd R.V. DNA methylation regulates p27kip1 expression in rodent pituitary cell lines. Am. J. Pathol. 153 (1998) 1475-1482
19. Orr R.B., and Kamen B.A. Identification of a point mutation in the folate receptor gene that confers a dominant negative phenotype. Cancer Res. 55 (1995) 847-852
20. Windle J.J., Weiner R.I., and Mellon P.L. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol. Endocrinol. 4 (1990) 597-603
21. Doucette M.M., and Stevens V.L. Folate receptor function is regulated in response to different cellular growth rates in cultured mammalian cells. J. Nutr. 131 (2001) 2819-2825
22. Onguru O., Scheithauer B., Kovacs K., Vidal S., Jin L., Zhang S., Ruebel K., and Lloyd R. Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas. Mod. Pathol. 17 (2004) 772-780
23. McCabe C., Khaira J., Boelaert K., Heaney A., Tannahill L., Hussain S., Mitchell R., Olliff J., Sheppard M., Franklyn J., and Gittoes N. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour, 1. Clin. Endocrinol. 58 2 (2003) 141-150
24. Bradshaw C., and Kakar S. Pituitary tumor transforming gene: an important gene in normal cellular functions and tumorigenesis. Histol. Histopathol. 22 (2007) 219-226
25. Gittoes N.J. Current perspectives on the pathogenesis of clinically non-functioning pituitary tumours. J. Endocrinol. 157 (1998) 177-186
26. Bottero F., Tomassetti A., Canevari S., Miotti S., Menard S., and Colnaghi M.I. Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo. Cancer Res. 53 (1993) 5791-5796
27. Toffoli G., Cernigoi C., Russo A., Gallo A., Bagnoli M., and Boiocchi M. Overexpression of folate binding protein in ovarian cancers. Int. J. Cancer 74 (1997) 193-198
28. Ilangumaran S., He H., and Hoessli D. Microdomains in lymphocyte signalling: beyond GPI-anchored proteins. Immunol. Today 21 (2000) 2-7
29. Horejsi V., Drbal K., Cebecauer M., Cerny J., Brdicka T., Angelisova P., and Stockinger H. GPI-microdomains: a role in signalling via immunoreceptors. Immunol. Today 20 (1999) 356-361
30. Miotti S., Bagnoli M., Tomassetti A., Colnaghi M.I., and Canevari S. Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1. J. Cell Sci. 113 (2000) 349-357
31. Hough C., Cho K., Zonderman A., Schwartz D., and Morin P. Coordinately up-regulated genes in ovarian cancer. Cancer Res. 61 (2001) 3869-3876
32. Dang T.P., Eichenberger S., Gonzalez A., Olson S., and Carbone D.P. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice. Oncogene 22 (2003) 1988-1997
33. Bellavia D., Campese A.F., Checquolo S., Balestri A., Biondi A., Cazzaniga G., Lendahl U., Fehling H.J., Hayday A.C., Frati L., von Boehmer H., Gulino A., and Screpanti I. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3788-3793
34. Dang L., Fan X., Chaudhry A., Wang M., Gaiano N., and Eberhart C. Notch3 signaling initiates choroid plexus tumor formation. Oncogene 25 (2006) 487-491
35. Gittoes N.J., McCabe C.J., Sheppard M.C., and Franklyn J.A. Estrogen receptor beta mRNA expression in normal and adenomatous pituitaries. Pituitary 1 (1999) 99-104
36. Semba S., Han S.Y., Ikeda H., and Horii A. Frequent nuclear accumulation of beta-catenin in pituitary adenoma. Cancer 91 (2001) 42-48
37. Grbavec D., Lo R., Liu Y., and Stifani S. Transducin-like Enhancer of split 2, a mammalian homologue of Drosophila Groucho, act as a transcriptional repressor, interacts with Hairy/Enhancer of split proteins, and is expressed during neuronal development. Eur. J. Biochem. 258 (1998) 339-349
38. Hasson P., and Paroush Z. Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE. Br. J. Cancer 94 (2006) 771-775